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Background
Cardiovascular morbidity is a well known late complica-
tion of chemotherapy, for example for treatment of testi-
cular cancer. In addition, development of a combination
of overweight, hypertension and abnormal lipid profiles
has been observed in these patients suggesting increased
risk of developing the metabolic syndrome and diabetes.
The early effects of chemotherapy on myocardial function
and metabolic profile are largely unknown. Therefore, the
purpose of this study was to assess short-term effects of
chemotherapy in testicular cancer on myocardial function
in relationship with alterations in metabolic profile.
Methods
Fourteen patients with testicular cancer were treated
with bleomycin, etoposide and cisplatin.
Before and after chemotherapy, magnetic resonance
imaging techniques were used to assess cardiac systolic
and diastolic function, and abdominal fat volume (sum-
mation of 3 slices at the level of the L5 vertebra). In
addition, hepatic and myocardial triglyceride content
were assessed using MR spectroscopy. Blood samples
were taken at both occasions to obtain plasma lipid pro-
file and to estimate insulin sensitivity.
Results
After chemotherapy, an unfavorable shift in metabolic
profile was observed: Visceral abdominal fat volume was
increased significantly (from186 ± 125 ml to 227 ± 162 ml.
P< 0.05) without significant changes in BMI. Hepatic tri-
glyceride content increased, although non-significant
(from 3.23 ± 2.72 % to 4.65 ± 4.85% P> 0.05). In addition
proxy-measures of insulin sensitivity (Quicki) decreased
from 0.39 ± 0.05 to 0.36 ± 0.05 P < 0.05 and serum LDL-
cholesterol increased significantly after chemotherapy
treatment from 3.12 ± 1.15 mmol/l to 3.74 ± 1.41 mmol/l.
These metabolic derangements were paralleled by sub-
clinical changes in myocardial function. Diastolic func-
tion, as assessed as the E/A ratio, decreased (from 1.87
± 0.43 to ± 1.64 ± 0.45 P< 0.05.) Furthermore, left ven-
tricular end-diastolic volume was decreased (from192 ±
27 ml. to 175 ± 26 ml. P< 0.05), indicating disturbed
ventricular relaxation. Myocardial systolic function and
myocardial triglyceride content were unaltered.
Conclusions
Chemotherapy for testicular cancer induces unfavorable
metabolic changes, which are paralleled by impairment
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